Agreement to undergo no changes in concomitant medications including dietary supplements or therapeutic interventions during the first 12 weeks of the study that is the 12 weeks of dosing with study drug except where medically indicated Stable concomitant drug regimen greater than two weeks pre-enrollment without changes 